Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Glatiramer acetate inhibits the activation of NFκB in the CNS of experimental autoimmune encephalomyelitis

Glatiramer acetate 투여에 의한 자가면역성 뇌척수염 마우스의 중추신경계에서의 NFκB 활성 억제

  • Hwang, Insun (College of Veterinary Medicine, Jeju National University) ;
  • Ha, Danbee (College of Veterinary Medicine, Jeju National University) ;
  • Kim, Dae Seung (College of Veterinary Medicine, Jeju National University) ;
  • Joo, Haejin (College of Veterinary Medicine, Jeju National University) ;
  • Jee, Youngheun (College of Veterinary Medicine, Jeju National University)
  • 황인선 (제주대학교 수의과대학 수의학과) ;
  • 하단비 (제주대학교 수의과대학 수의학과) ;
  • 김대승 (제주대학교 수의과대학 수의학과) ;
  • 주해진 (제주대학교 수의과대학 수의학과) ;
  • 지영흔 (제주대학교 수의과대학 수의학과)
  • Accepted : 2011.06.09
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Glatiramer acetate (GA; Copaxone) has been shown to be effective in preventing and suppressing experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS). It has been recently shown that GA-reactive T cells migrate through the blood-brain barrier, accumulate in the central nervous system (CNS), secrete antiinflammatory cytokines and suppress production of proinflammatory cytokines of EAE and MS. Development of EAE requires coordinated expression of a number of genes involved in the activation and effector functions of inflammatory cells. Activation of inflammatory cells is regulated at the transcriptional level by several families of transcription factors. One of these is the nuclear factor kappa B ($NF{\kappa}B$) family which is present in a variety of cell types and involved in the activation of immune-relative genes during inflammatory process. Since it is highly activated at site of inflammation, $NF{\kappa}B$ activation is also implicated in the pathogenesis of EAE. In this study, we examined whether the inhibition of $NF{\kappa}B$ activation induced by GA can have suppressive therapeutic effects in EAE mice. We observed the expression of $NF{\kappa}B$ and phospho-$I{\kappa}B$ proteins increased in GA-treated EAE mice compared to EAE control groups. The immunoreactivity in inflammatory cells and glial cells of $NF{\kappa}B$ and phospho-$I{\kappa}B$ significantly decreased at the GA-treated EAE mice. These results suggest that treatment of GA in EAE inhibits the activation of $NF{\kappa}B$ and phophorylation of $I{\kappa}B$ in the CNS. Subsequently, the inhibition of $NF{\kappa}B$ activation and $I{\kappa}B$ phosphorylation leads to the anti-inflammatory effects thereby to reduce the progression and severity of EAE.

Keywords

References

  1. Aharoni R, Teitelbaum D, Sela M, Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1997, 94, 10821-10826. https://doi.org/10.1073/pnas.94.20.10821
  2. Aharoni R, Teitelbaum D, Sela M, Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J Neuroimmunol 1998, 91, 135-146. https://doi.org/10.1016/S0165-5728(98)00166-0
  3. Barnes PJ, Karin M. Nuclear factor-${\kappa}$B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336, 1066-1071. https://doi.org/10.1056/NEJM199704103361506
  4. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HGW, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. $IKK{\beta}/NF-{\kappa}B$ activation causes severe muscle wasting in mice. Cell 2004, 119, 285-298. https://doi.org/10.1016/j.cell.2004.09.027
  5. Chen M, Gran B, Costello K, Johnson K, Martin R, Dhib-Jalbut S. Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS. Mult Scler 2001, 7, 209-219. https://doi.org/10.1177/135245850100700401
  6. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest 2000, 105, 967-976. https://doi.org/10.1172/JCI8970
  7. Flores N, Duran C, Blasco MR, Puerta C, Dorado B, Garcia-Merino A, Ballester S. NF${\kappa}$B and AP-1 DNA binding activity in patients with multiple sclerosis. J Neuroimmunol 2003, 135, 141-147. https://doi.org/10.1016/S0165-5728(02)00440-X
  8. Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Kwon OJ, Brenner T, Arnon R, Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity. Proc Natl Acad Sci USA 1994, 91, 4872-4876. https://doi.org/10.1073/pnas.91.11.4872
  9. Gran B, Tranquill LR, Chen M, Bielekova B, Zhou W, Dhib-Jalbut S, Martin R. Mechanisms of immunomodulation by glatiramer acetate. Neurology 2000, 55, 1704-1714. https://doi.org/10.1212/WNL.55.11.1704
  10. Grilli M, Chiu JJ, Lenardo MJ. NF-${\kappa}$B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143, 1-62.
  11. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of $I{\kappa}B-{\alpha}$ is necessary for activation of transcription factor NF-${\kappa}$B. Nature 1993, 365, 182-185. https://doi.org/10.1038/365182a0
  12. Hilliard B, Samoilova EB, Liu TST, Rostami A, Chen Y. Experimental autoimmune encephalomyelitis in NF-${\kappa}$B-deficient mice: roles of NF-${\kappa}$B in the activation and differentiation of autoreactive T cells. J Immunol 1999, 163, 2937-2943.
  13. Hwang I, Jee Y. Expression and Localization of phospho-I${\kappa}$B in the central nervous system during experimental autoimmune encephalomyelitis in Lewis rats. Korean J Vet Res 2005, 45, 7-15.
  14. Jee Y, Piao WH, Liu R, Bai XF, Rhodes S, Rodebaugh R, Campagnolo DI, Shi FD, Vollmer TL. $CD4^{+}CD25^{+}$ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin Immunol 2007, 125, 34-42. https://doi.org/10.1016/j.clim.2007.05.020
  15. Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J 2003, 22, 5079-5089. https://doi.org/10.1093/emboj/cdg474
  16. Miller A, Shapiro S, Gershtein R, Kinarty A, Rawashdeh H, Honigman S, Lahat N. Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immunedeviation. J Neuroimmunol 1998, 92, 113-121. https://doi.org/10.1016/S0165-5728(98)00191-X
  17. Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci USA 2000, 97, 7452-7457. https://doi.org/10.1073/pnas.97.13.7452
  18. Raine CS, Traugott U. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis. Ann N Y Acad Sci 1984, 436, 33-51. https://doi.org/10.1111/j.1749-6632.1984.tb14774.x
  19. Riminton DS, Körner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998, 187, 1517-1528. https://doi.org/10.1084/jem.187.9.1517
  20. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-${\kappa}$B signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008, 7, 83-105. https://doi.org/10.1016/j.arr.2007.09.002
  21. Schrempf W, Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 2007, 6, 469-475. https://doi.org/10.1016/j.autrev.2007.02.003
  22. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-B leads to multifocal defects in immune responses. Cell 1995, 80, 321-330. https://doi.org/10.1016/0092-8674(95)90415-8
  23. Teitelbaum D, Fridkis-Hareli M, Arnon R, Sela M. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLPspecific T cell responses. J Neuroimmunol 1996, 64, 209-217. https://doi.org/10.1016/0165-5728(95)00180-8
  24. Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. J Autoimmun 2000, 14, 205-211. https://doi.org/10.1006/jaut.2000.0370
  25. Vieira PL, Heystek HC, Wormmeester J, Wierenga EA, Kapsenberg ML. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J Immunol 2003, 170, 4483-4488. https://doi.org/10.4049/jimmunol.170.9.4483
  26. Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G, Dohlsten M. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 1995, 15, 235-253. https://doi.org/10.1615/CritRevImmunol.v15.i3-4.30